Medical Therapeutics

Magnetic Tides

Brief Description

Magnetic Tides has developed a new non-invasive brain stimulation (NIBS) system capable of modulating brain function more reliably and effectively than previously existing NIBS methods.

NIBS is used as a research tool to safely, transiently alter the excitability state of targeted neurons when testing causal hypotheses about brain-behavior relationships. In addition, clinicians have recognized the potential of NIBS as a new intervention in the treatment of neurological and psychiatric disorders.

Timeline 2019. Company founded Inventors

...

Mammoth Biosciences

Brief Description

Mammoth’s vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners - democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.

Timeline 2017. Company founded Inventors

Jennifer Doudna, Alexandra Seletsky, Amanda Mok, Brittney Wai-Li Thornton, David Frank Savage, Dylan Smock, Eli Dugan, Emeric Jean Charles, Gavin Knott, James Doudna Cate, John Desmarais, Liana Lareau,...

Mend Neuroscience, Inc.

Brief Description

Mend Neuroscience, Inc. is a therapeutics company treating cognitive disorders.

Timeline 2020. Company founded Inventors

Daniela Kaufer, Alon Friedman, Luisa Cacheaux

Mercator MedSystems Inc.

Brief Description

Mercator MedSystems, Inc. is a medical technology company focused on the treatment of peripheral artery disease utilizing its catheter-guided, microfluid infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. The Company's technology also enables the commercialization of novel therapeutics for other vascular diseases, hypertension, oncology, and regenerative medicine. The Company's Cricketª and Bullfrog Micro-Infusion Catheters are the first vascular-access systems able to infuse drugs, genes, and cells...

Nexilico

Brief Description

Nexilico, Inc. is an early-stage startup with the mission to advance microbiome and precision medicine research and development by developing next generation of predictive, computational platforms that improve drug design and development as well as therapeutics clinical outcome.

Timeline 2021. Company founded Inventor

Mohammad Mofrad

NanoNerve

Brief Description

NanoNerve is a medical device company developing tissue engineered implant solutions for neurosurgery. Their mission is to improve patient outcome by providing neurosurgeons with innovative solutions that encourage rapid neural tissue recovery and minimize complications. Using their patented aligned fiber technology platform we engineer graft implants with specific biophysical cues that enhance and direct neural tissue regeneration.

Timeline 2006. Company founded Inventors

Craig Hashi, Ngan Fong Huang, Kyle Kurpinski, Song Li, Shyam Patel

Nadaeon

Brief Description

Life sciences company.

Timeline 2021. Company founded Inventors

Danica Chen, Hanzhi Luo

Catalyst Biosciences, Inc.

Brief Description

Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines. Catalyst is focused on creating and commercializing novel medicines to address serious medical conditions for patients who need new or better treatment options.

Timeline 2002. Company founded 2015. Company merged, acquiring Targacept through a reverse merger, resulting in the combined entity trading on the NASDAQ under the ticker symbol CBIO 2023. Merges with, and...

CaseForge, Inc.

Brief Description

CaseForge produces personalized stabilizers for use in research and clinical imaging. These stabilizers interface with medical devices to precisely position the patient and eliminate motion, guaranteeing comfortable, fast, simple placement consistency across treatments.

The company was founded by graduate students in the lab of Dr. Jack Gallant, a professor in the UC Berkeley Department of Psychology, and an affiliate in Electrical Engineering and Computer Science, and programs in Neuroscience, Bioengineering, Biophysics and Vision...

Vedere Bio II

Brief Description

Vedere Bio II is pioneering beyond traditional gene therapy to not just slow vision loss from inherited retinal degenerations (IRDs) or dry age-related macular degeneration (dry AMD) with geographic atrophy (GA), but actually restore it.

Timeline 2021. Vedere Bio II launches as the successor to the first Vedere Bio, which was acquired by Novartis in September 2020 Inventors

Matthew Banghart, Michael Hayden Berry, Katherine Borges, Johannes Broichhagen, John Flannery, Doris Fortin, Benjamin Gaub, Scott Franklin Geller, Pablo Gorostiza, Karen...